Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

The FDA has approved the expanded use of Botox® (onabotulinumtoxinA; Allergan) for the treatment of spasticity in pediatric patients aged ≥2 years, including those with lower limb spasticity caused by ...

Many people with multiple sclerosis have stiff muscles and spasms, a condition called spasticity. It happens mostly in the muscles of the legs and arms, and it may keep you from moving your limbs ...

Spasticity is a condition that causes your muscles to stiffen, tighten, and contract. It happens involuntarily, which means you don’t have control over it. Spasticity typically happens because of ...

(CBS News) Smoking marijuana may provide relief from multiple sclerosis symptoms, a new study suggests. People with MS who smoked pot reported less pain and spasticity - or muscle tightness - but it ...

Spasticity most often develops in upper motor neuron types of injuries. It is a motor disorder defined as velocity dependent, increased resistance to passive muscle stretch. It is an exaggeration of ...

The involuntary muscle spasms that occur as a result of neuromotor disorders and spinal cord injury can have dangerous consequences for affected individuals. New findings shed light on one mechanism ...

Spasticity is a condition that causes your muscles to stiffen or tighten, which can cause mild pain to severe muscle spasms. If you are living with spasticity, you may find that using an assistive ...

The global Spasticity Treatment Market is worth US$ 13.1 Billion as of now and is expected to reach US$ 28.4 Billion by the year 2033 at a CAGR of 8.1% between 2023 and 2033. Spasticity is turning out ...

Spasticity, a phenomenon associated with the upper motor neuron syndrome, was defined by James W. Lance as "a motor disorder characterized by a velocity-dependent increase in tonic stretch reflex ...